Prelude Capital Management’s AMN Healthcare AMN Stock Holding History

Prelude Capital Management’s Portfolio AMN Stock Details AMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-12,000	Closed	-$1.16M	–	1708
2021 Q2	$1.16M	Hold	12,000	–	–	0.03%	531
2021 Q1	$884K	Hold	12,000	–	–	0.02%	646
2020 Q4	$819K	Hold	12,000	–	–	0.02%	544
2020 Q3	$702K	Buy	+12,000	New	+$632K	0.03%	351

Other funds holding AMN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Prelude Capital Management's AMN Position: Q1 2026 in Review

Prelude Capital Management sold out of AMN Healthcare (AMN) in Q1 2026, closing a stake of 18,300 shares — an estimated $288K sold.

Prelude Capital Management first reported a position in AMN in Q1 2014 and held it in 21 quarters. The position peaked at $1.45M in Q2 2021. 249 funds tracked by Wall St. Rank hold AMN as of Q1 2026.

Prelude Capital Management reported no remaining AMN Healthcare position as of Q1 2026 after selling out during the quarter.
Prelude Capital Management sold 18,300 AMN Healthcare shares in Q1 2026, an estimated $288K.
Prelude Capital Management first reported a position in AMN Healthcare in Q1 2014 and held it in 21 quarters.
Prelude Capital Management's AMN Healthcare position peaked at $1.45M in Q2 2021.
249 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.